Biogen Pharmachem Industries share news and announcements

BSE: 531752FinanceSmall Cap

₹0.24₹0.00 (0.00%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹0.24.

52-week range of traded prices to 23 Oct 2026

₹0.23Low, 23 Oct 2026₹0.73High, 23 Oct 2025

Market cap: ₹25 Cr3,446th largest listed
P/E: Earlier quarters restated in the year
P/B: 0.3
Dividend yield: Nonein the last 12 months
ROCE: −0.6%
Debt to equity: 0.00
Volume, BSE: 24,98,763

Biogen Pharmachem Industries share news and announcements

509 announcements, routine notices left out, newest first. Page 2 of 11.

Jul 2025
- 23 Jul · Business
  Nil Statement On Deviation Or Variation Of Funds Raised Through Preferential Issue (opens in a new tab)
- 23 Jul
  Regulations 30, 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (opens in a new tab)
- 23 Jul · Results
  Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors .... (opens in a new tab)
- 16 Jul · Board meeting
  Meeting on 23 Jul 2025: quarterly results
- 16 Jul · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 23/07/2025 ,inter alia, to consider and approve Pursuant to Regulation .... (opens in a new tab)
May 2025
- 23 May
  Regulations 30, 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (opens in a new tab)
- 23 May · Board meeting
  This is to inform you that Outcome of the Board Meeting of the Company held on Friday 23rd May, 2025 in accordance with SEBl (Listing Obligations and Disclosures Requirements) Regulations, .... (opens in a new tab)
- 12 May · Board meeting
  Meeting on 23 May 2025: audited results
- 12 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 23/05/2025 ,inter alia, to consider and approve PFA (opens in a new tab)
Apr 2025
- 15 Apr · Board meeting
  Meeting on 15 Apr 2025: preferential issue of shares
- 15 Apr · Board meeting
  This is to Inform you that at the Meeting of the Board of Directors of the Company held today on Tuesday, 15th April 2025 It has further informed that all final call is called up on .... (opens in a new tab)
- 8 Apr · Board meeting
  Meeting on 8 Apr 2025
- 8 Apr · Board meeting
  Board Meeting Outcome for Outcome Of Board Meeting Held On Today 08.04.2025 (opens in a new tab)
Mar 2025
- 27 Mar · Board meeting
  We wish to inform that the Board of Directors in their meeting held today, i.e., March 27, 2025, inter-alia, considered and approved the following items: 1. Allotment of 25,00,00,000 .... (opens in a new tab)
- 21 Mar · Board meeting
  We wish to inform that the Board of Directors in their meeting held today, i.e., March 21, 2025, inter-alia, considered and approved the following items: 1. Allotment of 25,00,00,000 .... (opens in a new tab)
- 11 Mar · Board meeting
  Meeting on 11 Mar 2025
- 11 Mar · Board meeting
  We wish to inform that the Board of Directors in their meeting held today, i.e., March 11, 2025, inter-alia, considered and approved the following items: 1. Allotment of 25,00,00,000 .... (opens in a new tab)
- 8 Mar
  Updation Of Website Of The Company On Corporate Information (opens in a new tab)
- 7 Mar · Board meeting
  Meeting on 7 Mar 2025
- 7 Mar · Board meeting
  We wish to inform that the Board of Directors in their meeting held today, Le., March 7, 2025, inter-alia, considered and approved the following items: 1. Allotment of 25,00,00,000 (Twenty-Five .... (opens in a new tab)
Feb 2025
Jan 2025
- 22 Jan · Board meeting
  Meeting on 5 Feb 2025: quarterly results
- 22 Jan · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 05/02/2025 ,inter alia, to consider and approve Pursuant to Regulation .... (opens in a new tab)
- 17 Jan · Board meeting
  We wish to inform that the Board of Directors in their meeting held today, i.e., January 17 2025, inter-alia, considered and approved the following items: 1. Allotment of 25,00,00,000 .... (opens in a new tab)
Nov 2024
- 29 Nov · Board meeting
  Meeting on 29 Nov 2024
- 29 Nov · Board meeting
  We wish to inform that the Board of Directors in their meeting held today, i.e., 29th November 2024, inter-alia, considered and approved the following items: 1. Allotment of 25,00,00,000 .... (opens in a new tab)
- 13 Nov · Results
  Un-Audited Financial Result Quarter And Half Year Ended On 30Th September 2024 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015. (opens in a new tab)
- 13 Nov · Results
  Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of t he SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of .... (opens in a new tab)
Oct 2024
- 15 Oct · Board meeting
  Meeting on 13 Nov 2024: quarterly results
- 15 Oct · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 13/11/2024 ,inter alia, to consider and approve PFA (opens in a new tab)
Sep 2024
Aug 2024
- 13 Aug · Business
  Announcement under Regulation 30 (LODR)-Preferential Issue (opens in a new tab)
- 13 Aug · Board meeting
  Board Meeting Outcome for OUTCOME OF THE MEETING OF BOARD OF DIRECTORS HELD ON FRIDAY 9TH AUGUST 2024 PURSUANT TO REGULATION 30 OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 (opens in a new tab)
- 9 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 13/08/2024 ,inter alia, to consider and approve Pursuant to regulation .... (opens in a new tab)
- 1 Aug · Board meeting
  Meeting on 13 Aug 2024: preferential issue of shares
- 1 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 09/08/2024 ,inter alia, to consider and approve PFA (opens in a new tab)
- 1 Aug · Results
  Un-Audited Financial Result Quarter Ending 30Th June, 2024 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015 (opens in a new tab)
- 1 Aug · Board meeting
  Board Meeting Outcome for Un-Audited Financial Result Quarter Ending 30Th June, 2024 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015 (opens in a new tab)
Jul 2024
- 25 Jul · Board meeting
  Meeting on 1 Aug 2024: quarterly results
- 25 Jul · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 01/08/2024 ,inter alia, to consider and approve 1.) To approve .... (opens in a new tab)
- 11 Jul
  Updation Of Website Of The Company (opens in a new tab)
May 2024
- 25 May · Board meeting
  Outcome of the Board Meeting held on 25th May 2024. (opens in a new tab)
- 25 May · Results
  Audited Financial Results for the Quarter and Year Ended on 31st March, 2024 (opens in a new tab)
- 16 May · Board meeting
  Meeting on 25 May 2024: audited results

Biogen Pharmachem Industries share news and announcements

Jul 2025

May 2025

Apr 2025

Mar 2025

Feb 2025

Jan 2025

Nov 2024

Oct 2024

Sep 2024

Aug 2024

Jul 2024

May 2024